ChemicalBook >> CAS DataBase List >>Emibetuzumab
Emibetuzumab
- CAS No.
- 1365287-97-3
- Chemical Name:
- Emibetuzumab
- Synonyms
- LY2875358;Emibetuzumab;Emibetuzumab (anti-MET);Research Grade Emibetuzumab(DHC34201)
- CBNumber:
- CB28080907
- Molecular Formula:
- Molecular Weight:
- 0
- MDL Number:
- MOL File:
- Mol file
Last updated:2024-07-02 08:55:04
form | Liquid |
---|---|
color | Colorless to light yellow |
FDA UNII | MO4K3GDN1I |
Emibetuzumab Chemical Properties,Uses,Production
Description
Emibetuzumab is a bivalent antibody that blocks HGF- and MET-receptor interaction, leading to MET internalization and degradation.
Clinical Use
A phase I study determined a tolerable dose for emibetuzumab to be 700–2000 mg as a monotherapy and in combination with erlotinib in NSCLC patients. It is currently being investigated in phase II in combination with erlotinib.
Emibetuzumab Preparation Products And Raw materials
Raw materials
Preparation Products
Emibetuzumab Suppliers
Global( 10)Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Aladdin Scientific | +1-+1(833)-552-7181 | sales@aladdinsci.com | United States | 57511 | 58 |
ShangHai Biochempartner Co.,Ltd | 17754423994 17754423994 | 2853530910@QQ.com | China | 8014 | 62 |
Guangzhou Hongyuan Chemical Co.,Ltd | 15817493340 | 981810490@qq.com | China | 1565 | 58 |
Wuhan Chemstan Biotechnology Co., Ltd. | 027-65317797 15926423062 | 422450190@qq.com | China | 10351 | 58 |
AntibodySystem | 027-65279366 18162686757 | products@biolabreagent.com | China | 9818 | 58 |
Wuhan Jingkangen Biomedical Technology Co., Ltd | 13720134139 13720134139 | orders@jknbiochem.com | China | 5601 | 58 |
Shanghai Aladdin Biochemical Technology Co.,Ltd. | +86-18521732826 | market@aladdin-e.com | China | 48465 | 58 |
Changsha Fuzhen Biotechnology Co.,LTD | 13823398779 18670069958 | 313359644@qq.com | China | 3195 | 58 |
TargetMol Chemicals Inc. | 15002134094 | marketing@targetmol.cn | China | 28070 | 58 |
Olix (Shanghai) Pharmaceutical Technology Co., Ltd | 17316404525 | 209533805@qq.com | China | 9723 | 58 |
Emibetuzumab
Research Grade Emibetuzumab(DHC34201)
Emibetuzumab (anti-MET)
LY2875358
1365287-97-3